Top compounds associated with response to TIGD2


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel CCLE pan-cancer AAC -0.089 0.05
mRNA MP470 GDSC1000 pan-cancer AAC -0.067 0.05
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.068 0.05
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.072 0.05
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.067 0.05
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.067 0.05
mRNA GDC-0941 GDSC1000 pan-cancer AAC -0.064 0.05
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC -0.098 0.06
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.1 0.06
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC 0.073 0.06
Download CSV